I agree that an update is due on the non-price sensitive items.
I don't agree that an update is OVERdue.
I'd rather management work on designing trials, lodging patent applications and whatever the underwater part of the iceberg is.
Ann: Zantrene highly effective in Melanoma preclinical study, page-170
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.77 |
Change
-0.070(3.80%) |
Mkt cap ! $308.2M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.89 | $1.76 | $215.3K | 120.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10323 | $1.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 1100 | 1 |
View Market Depth
| Last trade - 11.40am 24/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |